Particle.news
Treatment Options Semaglutide GLP-1 Receptor Agonists Prediabetes Oral Medications Insulin Efsitora Alfa Efsitora Alfa Medication Use in Children Diabetes Management GLP-1 Medications Mounjaro Medication Effects Blood Sugar Management Medication Access Weight Loss Medications Management Strategies Pre-diabetes
The first nonpeptide oral GLP-1 therapy, orforglipron, matches injectable drugs in weight-loss and glucose-control efficacy, with FDA filings planned for late 2025.
